MeCP2 links heterochromatin condensates and neurodevelopmental disease

Charles H. Li, Eliot L. Coffey, Alessandra Dall’Agnese, Nancy M. Hannett, Xin Tang, Jonathan E. Henninger, Jesse M. Platt, Ozgur Oksuz, Alicia V. Zamudio, Lena K. Afeyan, Jurian Schuijers, X. Shawn Liu, Styliani Markoulaki, Tenzin Lungjangwa, Gary LeRoy, Devon S. Svoboda, Emile Wogram, Tong Ihn Lee, Rudolf Jaenisch*, Richard A. Young

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Abstract

Methyl CpG binding protein 2 (MeCP2) is a key component of constitutive heterochromatin, which is crucial for chromosome maintenance and transcriptional silencing1–3. Mutations in the MECP2 gene cause the progressive neurodevelopmental disorder Rett syndrome3–5, which is associated with severe mental disability and autism-like symptoms that affect girls during early childhood. Although previously thought to be a dense and relatively static structure1,2, heterochromatin is now understood to exhibit properties consistent with a liquid-like condensate6,7. Here we show that MeCP2 is a dynamic component of heterochromatin condensates in cells, and is stimulated by DNA to form liquid-like condensates. MeCP2 contains several domains that contribute to the formation of condensates, and mutations in MECP2 that lead to Rett syndrome disrupt the ability of MeCP2 to form condensates. Condensates formed by MeCP2 selectively incorporate and concentrate heterochromatin cofactors rather than components of euchromatic transcriptionally active condensates. We propose that MeCP2 enhances the separation of heterochromatin and euchromatin through its condensate partitioning properties, and that disruption of condensates may be a common consequence of mutations in MeCP2 that cause Rett syndrome.

Original languageEnglish (US)
Pages (from-to)440-444
Number of pages5
JournalNature
Volume586
Issue number7829
DOIs
StatePublished - Oct 15 2020

Funding

Acknowledgements We thank A. P. Bird for sharing Mecp2 mutant cell lines; D. Reinberg for sharing purified poly-nucleosomes; P. A. Sharp for discussions; D. Richardson and the Harvard Center for Biological Imaging; W. Salmon and the Whitehead W.M. Keck Microscopy Facility; and R. Flannery, J. Drotar, N. Rosenau and the Whitehead Genetically Engineered Models Center for technical support. The work was supported by NIH grant R01 GM123511 (R.A.Y.), NSF grant PHY1743900 (R.A.Y.), NIH grant 2 R01 MH104610-20 (R.J., R.A.Y.), NIH grant R37 CA084198 (R.J.), Hope Funds for Cancer Research Fellowship (A.D.), NIH grant T32 5T32DK007191-45 (J.M.P.), NSF Graduate Research Fellowship (A.V.Z.), and NIH grant K99/R00 MH113813 (X.S.L.). MECP2 gene expression values in transcripts per million (TPM) from RNA-seq of human tissues were acquired from the Genotype-Tissue Expression (GTEx) project release v.7. In instances where multiple regions of the same tissue were assayed, the highest expression value was used to represent the tissue. TPM values greater than 1 were considered to be expressed. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS.

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'MeCP2 links heterochromatin condensates and neurodevelopmental disease'. Together they form a unique fingerprint.

Cite this